Table 2.
Outcomes | Group 1 (%) | Group 2 (%) | p-Value univariate |
---|---|---|---|
Relapse at 5 yearsa | 36 ± 13 | 84 ± 14 | 0.025 |
Overall survival at 5 yearsa | 52 ± 11 | 17 ± 10 | 0.12 |
Event-free survival at 5 yearsa | 43 ± 11 | 8 ± 8 | 0.09 |
Neutrophil recovery at day 25b | 76 ± 9 | 67 ± 13 | 0.33 |
Platelet recovery at day 100b | 83 ± 8 | 92 ± 8 | 0.72 |
Non-relapse mortalityb | 38 | 41 | 0.81 |
Acute GVHD II–IV incidenceb | 38 | 75 | 0.04 |
Chronic GHVD incidenceb | 14 | 36 | 0.16 |
aKaplan–Meier estimate.
bCumulative incidence.
GVHD, graft-vs.-host disease.